International REACH Forgiveness Intervention

Six sites spanning five regions (Hong Kong, Colombia, Indonesia, Ukraine, South Africa) will administer a forgiveness workbook intervention in a randomized design with a stepped, waitlist intervention deployment.

Study Overview

• Status: Completed
• Conditions: Mental Health Wellness
• Intervention / Treatment: Behavioral: REACH Forgiveness Workbook Intervention

Detailed Description

Intervention deployment:

ODO1 X O2 O3 (immediate-treatment [IT ] group) ODO1 O2 X O3 (delayed-treatment [DT ] group)

where OD denotes measurement of baseline demographic and personality measures, X denotes deployment of the intervention, and O1, O2, and O3 denote measurements of outcomes.

• Study Type: Interventional
• Enrollment (Actual): 4598
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Colombia
  • Cordoba, Colombia
    • Universidad del Sinú
• Indonesia
  • Depok, Indonesia
    • Universitas Gunadarma
• South Africa
  • Pretoria, South Africa
    • The South African and Africa Chapter of the International Association of Assessing Officers
• Ukraine
  • Kyiv, Ukraine
    • Realis Center for Education and Research
  • Kyiv, Ukraine
    • Ukrainian Institute of Arts and Sciences

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 14 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

• Must be able to read and comprehend the materials in the workbook
• Must be 18 years old or above
• Have someone in mind they want to forgive

Exclusion Criteria:

• No

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Other
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Immediate Treatment; Participants in this group will receive treatment/intervention immediately.	Behavioral: REACH Forgiveness Workbook Intervention; Participants will be asked to complete the REACH Forgiveness Workbook
Experimental: Delayed Treatment; Participant in this group will receive treatment/intervention 2-week later.	Behavioral: REACH Forgiveness Workbook Intervention; Participants will be asked to complete the REACH Forgiveness Workbook

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Depression (BSI)	Brief Symptom Index, minimum value = 0, maximum value = 4. Higher scores indicates a higher psychological distress.	4 months
Anxiety (BSI)	Brief Symptom Index. minimum value = 0, maximum value = 4. Higher scores indicates a higher psychological distress.	4 months
Forgiveness (TRIM)	Transgression-Related Interpersonal Motivations, minimum value = 1, maximum value = 5. The higher the score, the more unforgiving the person is.	4 months

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Trait Forgiveness (TSF)	Trait Forgiveness Scale, minimum value = 1, maximum value = 5. The higher the whole score, the more forgiveness the person is.	4 months
Forbearance (FS)	Forbearance Scale, minimum value = 1, maximum value = 6. The higher the score, the higher forbearing the person is.	4 months
Decision to Forgive (DTSF)	Decision to Forgive Scale, minimum value = 1, maximum value = 5. The higher the score, the higher decisional forgiveness of the subject.	4 months
Flourishing	Flourishing Index, minimum value = 1, maximum value = 10. The higher the score, the higher flourishing of the subject.	4 months

Collaborators and Investigators

• Sponsor: City University of Hong Kong
• Collaborators: Stanford University; Harvard University
• Investigators: Principal Investigator: Man Yee Ho, PhD, City University of Hong Kong

Study record dates

Study Major Dates

• Study Start (Actual): February 11, 2020
• Primary Completion (Actual): October 25, 2021
• Study Completion (Actual): October 25, 2021

Study Registration Dates

• First Submitted: February 4, 2020
• First Submitted That Met QC Criteria: February 4, 2020
• First Posted (Actual): February 6, 2020

Study Record Updates

• Last Update Posted (Actual): January 5, 2024
• Last Update Submitted That Met QC Criteria: January 4, 2024
• Last Verified: January 1, 2024

More Information

Terms related to this study

• Other Study ID Numbers: CityUHK

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: YES
• IPD Plan Description: Data, which will be used for meta-analysis, reproducibility, and replication purposes, will be disclosed after the embargo period (30 April, 2024).
• IPD Sharing Time Frame: After the embargo period (30 April, 2024)
• IPD Sharing Supporting Information Type: STUDY_PROTOCOL; ANALYTIC_CODE

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No